Right (RV) and left (LV) ventricular volume characteristics were determined from biplane cineangiography in 29 patients with atrioventricular canal (AVC). The patients were classified into two groups: group I (N = 19), uncomplicated AVC; group II (N = 10), AVC associated with RV obstruction. In group I, LV end-diastolic volume (EDV) [177 +/- 9 (SEM)% of normal] and RVEDV (125 +/- 9%) both were greater than normal (P is less than 0.001 and less than 0.01, respectively). LV ejection fraction (EF) was decreased (0.59 +/- 0.02, P is less than 0.001) but RVEF was normal (0.58 +/- 0.03). LV stroke volume index (SVI) was increased (48 +/- 3 ml/m2, P is less than 0.005), and RVSVI was normal (34 +/- 3 ml/m2). One patient had a markedly small RVEDV (45%). In group II, LVEDV and RVEDV were not different from normal (119 +/- 11% and 97 +/- 15%, respectively). LVEF was depressed (0.52 +/- 0.04, P is less than 0.001) and RVEF was normal (0.55 +/- 0.05). LVSVI was normal (38 +/- 5 ml/m2) and RVSVI was slightly decreased (29 +/- 4 ml/m2, P is less than 0.025). Two patients had a markedly small RVEDV (31%, 55%). EDV correlated with the pulmonary-to-systemic flow ratio (LV, r = 0.71; RV, r = 0.68). The data show that in most patients with AVC, LV and RV are enlarged in the uncomplicated form but not in the form with RV obstruction. LV function is more compromised than RV in both groups. RV hypoplasia is rare but was documented in both uncomplicated forms and forms with RV obstruction.

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.cir.57.5.991DOI Listing

Publication Analysis

Top Keywords

+/- ml/m2
16
+/-
12
left ventricular
8
ventricular volume
8
volume characteristics
8
atrioventricular canal
8
0001 rvef
8
rvef normal
8
normal +/-
8
markedly small
8

Similar Publications

Background And Objectives: Cryptogenic strokes account for 20%-25% of all ischemic strokes. Although atrial cardiopathy markers are more prevalent in the cryptogenic embolic stroke of undetermined source (ESUS) subgroup than in the nonembolic stroke subgroup, the utility of individual parameters in predicting cardioembolic sources needs to be studied further. We studied the clinical, imaging, and atrial cardiopathy markers in three ischemic stroke subtypes - large artery atherosclerosis (LAA), cardioembolism (CE), and cryptogenic ESUS - and their role in predicting the source of CE.

View Article and Find Full Text PDF

Aims: Atrial septal defect (ASD) and partial abnormal pulmonary venous connection (PAPVC) are noncyanotic congenital heart defects (CHD) that produce a left-to-right shunt. This single-center retrospective study aimed to assess the hemodynamic impact of isolated ASD, isolated PAPVC, and ASD-associated PAPVC using cardiovascular magnetic resonance (CMR).

Methods And Results: From our CMR registry (2002-2024), 110 patients were included: isolated ASD (n=64), isolated PAPVC (n=18), ASD-associated PAPVC (n=28, mostly sinus venosus septal defects).

View Article and Find Full Text PDF

Aim: To study the factors that influence the occurrence of postoperative atrial fibrillation (POAF) in patients with chronic ischemic heart disease (IHD) after coronary artery bypass grafting (CABG).

Material And Methods: This single-center prospective observational non-randomized study included 152 patients with chronic IHD. Mean age of patients was 64.

View Article and Find Full Text PDF

Aims: Left ventricular (LV) ring-like scar on cardiac magnetic resonance (CMR) has been linked to malignant arrhythmias in patients with non-ischemic cardiomyopathy. This study aimed to perform a comprehensive evaluation of this phenotype and to identify risk factors for life-threatening arrhythmic events (LAEs), a composite of sudden cardiac death (SCD), aborted SCD, and sustained ventricular tachycardia.

Methods And Results: One-hundred-fifteen patients (median age 39 [IQR 28-52], 42% females) were identified at 6 referral centres.

View Article and Find Full Text PDF
Article Synopsis
  • Hypertrophic obstructive cardiomyopathy (HOCM) is a genetic heart condition that leads to thickening of the heart muscle and obstructs blood flow from the left ventricle, making treatment challenging.
  • Mavacamten, a new drug that inhibits cardiac myosin, has shown significant effectiveness in reducing left ventricular outflow tract (LVOT) gradients and improving other heart-related measurements in patients with HOCM, based on a meta-analysis of two randomized controlled trials involving 332 patients.
  • The drug not only demonstrated beneficial effects but also had a favorable safety profile, suggesting it could change how HOCM is managed, although further long-term studies are needed to confirm its effectiveness and safety.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!